Park MB, Ranabhat CL. Park and Ranabhat Archives of Public Health COVID-19 trends, public restrictions policies and vaccination status by economic ranking of countries: a longitudinal study from 110 countries. Published online 2021. doi:10.1186/s13690-022-00936-w
2. Worldometer. Coronavirus Graphs: Worldwide Cases and Deaths. 2023. https://www.worldometers.info/coronavirus/worldwide-graphs/#daily-cases
3. Biancolella M, Colona VL, Mehrian-Shai R, Watt JL, Luzzatto L, Novelli G, Reichardt JKV. COVID-19 2022 update: transition of the pandemic to the endemic phase. Hum Genomics. 2022 Jun 1;16(1):19. doi: 10.1186/s40246-022-00392-1. PMID: 35650595; PMCID: PMC9156835.
4. RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17. PMID: 32678530; PMCID: PMC7383595.
5. COVID-19 Treatment Guidelines. Corticosteroids. 2022. https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/corticosteroids/
6. Ma S, Xu C, Liu S, et al. Efficacy and safety of systematic corticosteroids among severe COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials. Signal Transduct Target Ther. 2021;6(1). doi:10.1038/S41392-021-00521-7
7. Tomazini BM, Maia IS, Cavalcanti AB, et al. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA. 2020;324(13):1. doi:10.1001/JAMA.2020.17021
8. Crothers K, DeFaccio R, Tate J, et al. Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support. Eur Respir J. 2022;60(1). doi:10.1183/13993003.02532-2021
9. Ranjbar K, Moghadami M, Mirahmadizadeh A, et al. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis. 2021;21(1):1-8. doi:10.1186/S12879-021-06045-3/FIGURES/2
10. Raju R, V P, Biatris PS, J SJUC. Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials. Futur J Pharm Sci. 2021;7(1):67. doi: 10.1186/s43094-021-00217-3. Epub 2021 Mar 17. PMID: 33754123; PMCID: PMC7968560.
11. Singh AK, Majumdar S, Singh R, Misra A. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):971-978. doi: 10.1016/j.dsx.2020.06.054. Epub 2020 Jun 27. PMID: 32610262; PMCID: PMC7320713.
12. Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020 May 7;55(5):2001009. doi: 10.1183/13993003.01009-2020. PMID: 32341100; PMCID: PMC7236828.
13. Lee SC, Son KJ, Han CH, Jung JY, Park SC. Association between Inhaled Corticosteroid Use and SARS-CoV-2 Infection: A Nationwide Population-Based Study in South Korea. Tuberc Respir Dis (Seoul). 2022 Jan;85(1):80-88. doi: 10.4046/trd.2021.0102. Epub 2021 Nov 30. PMID: 34844402; PMCID: PMC8743634.
14. Ezer N, Belga S, Daneman N, et al. Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial. BMJ. 2021;375. doi:10.1136/BMJ-2021-068060
15. Clemency BM, Varughese R, Gonzalez-Rojas Y, et al. Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19: A Randomized Clinical Trial. JAMA Intern Med. 2022;182(1):42-49. doi:10.1001/JAMAINTERNMED.2021.6759
16. Yu LM, Bafadhel M, Dorward J, et al. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021;398(10303):843-855. doi:10.1016/S0140-6736(21)01744-X
17. Ramakrishnan S, Nicolau D v., Langford B, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021;9(7):763-772. doi:10.1016/S2213-2600(21)00160-0
18. Burhan E, Dwi Susanto A, Isbaniah F, et al. PEDOMAN TATALAKSANA COVID-19 Edisi 4 TIM EDITOR Perhimpunan Dokter Paru Indonesia (PDPI) Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI) Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI) Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia (PERDATIN) Ikatan Dokter Anak Indonesia (IDAI). 2022.
19. CDC. Corticosteroids, antibiotics generally not recommended for COVID-19 outpatients | AHA News. 2022. https://www.aha.org/news/headline/2022-04-26-cdc-corticosteroids-antibiotics-generally-not-recommended-covid-19
20. Patel VK, Shirbhate E, Patel P, Veerasamy R, Sharma PC, Rajak H. Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent. Beni Suef Univ J Basic Appl Sci. 2021;10(1):78. doi: 10.1186/s43088-021-00165-0. Epub 2021 Nov 4. PMID: 34751250; PMCID: PMC8567120.
21. El-Saber Batiha G, Al-Gareeb AI, Saad HM, Al-Kuraishy HM. COVID-19 and corticosteroids: a narrative review. Inflammopharmacology. 2022 Aug;30(4):1189-1205. doi: 10.1007/s10787-022-00987-z. Epub 2022 May 13. PMID: 35562628; PMCID: PMC9106274.